anmelden
OMX Nordic 40
2.612,92
PKT
+0,51
PKT
+0,02
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 14.10.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 13.10.21 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 13.10.21 | Kone Sector Perform | RBC Capital Markets | |
| 13.10.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 11.10.21 | AstraZeneca Buy | Deutsche Bank AG | |
| 11.10.21 | Ericsson (Telefon L.M.Ericsson) (B) Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.10.21 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.10.21 | Ericsson (Telefon L.M.Ericsson) (B) Overweight | Barclays Capital | |
| 07.10.21 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.10.21 | Volvo (B) Overweight | JP Morgan Chase & Co. | |
| 06.10.21 | Hennes Mauritz (H M, H&M) Sell | Deutsche Bank AG | |
| 05.10.21 | Volvo (B) Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.10.21 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 01.10.21 | Kone Overweight | JP Morgan Chase & Co. | |
| 01.10.21 | Hennes Mauritz (H M, H&M) Underperform | Credit Suisse Group | |
| 30.09.21 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 30.09.21 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
| 30.09.21 | Hennes Mauritz (H M, H&M) Neutral | Goldman Sachs Group Inc. | |
| 30.09.21 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
| 29.09.21 | AstraZeneca Buy | Deutsche Bank AG | |
| 28.09.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 28.09.21 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 28.09.21 | Nokia Buy | Goldman Sachs Group Inc. | |
| 28.09.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 27.09.21 | Volvo (B) Buy | Jefferies & Company Inc. | |
| 24.09.21 | AstraZeneca Overweight | Barclays Capital | |
| 24.09.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 24.09.21 | AstraZeneca Buy | UBS AG | |
| 24.09.21 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 24.09.21 | Volvo (B) Overweight | JP Morgan Chase & Co. | |
| 23.09.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 21.09.21 | Hennes Mauritz (H M, H&M) Buy | Kepler Cheuvreux | |
| 20.09.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 20.09.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 17.09.21 | AstraZeneca Overweight | Morgan Stanley | |
| 15.09.21 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
| 15.09.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.09.21 | Hennes Mauritz (H M, H&M) Overweight | JP Morgan Chase & Co. | |
| 15.09.21 | AstraZeneca Buy | UBS AG | |
| 15.09.21 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. |